XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Share Capital
 9 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Share Capital

18. SHARE CAPITAL

CANOPY GROWTH

Authorized

An unlimited number of common shares.

(i) Equity financings

There were no equity financings during the nine months ended December 31, 2022 (nine months ended December 31, 2021 - none).

(ii) Other issuances of common shares

During the nine months ended December 31, 2022, the Company issued the following common shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions:

 

 

 

Number of common shares

 

 

Share
capital

 

 

Share
based
reserve

 

Jetty Agreements

 

 

8,426,539

 

 

$

59,013

 

 

$

-

 

HSCP Holders pursuant to Amended TRA

 

 

5,648,927

 

 

 

20,630

 

 

 

-

 

Completion of acquisition milestones

 

 

222,421

 

 

 

1,379

 

 

 

(1,379

)

Other issuances

 

 

237,802

 

 

 

1,209

 

 

 

(353

)

Total

 

 

14,535,689

 

 

$

82,231

 

 

$

(1,732

)

 

For the three and nine months ended December 31, 2022, the Company also issued 8,692,128 common shares with a value of $26,506 relating to its redemption of the redeemable noncontrolling interest in BioSteel. The redemption increases the Company's interest in BioSteel from 78.6% to 90.3%.

 

During the nine months ended December 31, 2021, the Company issued the following common shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions:

 

 

 

Number of common shares

 

 

Share
capital

 

 

Share
based
reserve

 

Acquisition of Supreme Cannabis

 

 

9,013,400

 

 

$

260,668

 

 

$

-

 

Completion of acquisition milestones

 

 

1,295,285

 

 

 

29,276

 

 

 

(29,721

)

Other issuances

 

 

351,252

 

 

 

6,630

 

 

 

(405

)

Total

 

 

10,659,937

 

 

$

296,574

 

 

$

(30,126

)

 

(iii) Warrants

 

 

 

Number of
whole
warrants

 

 

Average
exercise
price

 

 

Warrant
value

 

Balance outstanding at March 31, 20221

 

 

128,193,047

 

 

$

58.04

 

 

$

2,581,788

 

Expiry of warrants

 

 

-

 

 

 

-

 

 

 

-

 

Balance outstanding at December 31, 20221

 

 

128,193,047

 

 

$

58.04

 

 

$

2,581,788

 

 

1 This balance excludes the Tranche C Warrants (as defined below), which represent a derivative liability and have nominal value. See Note 29.

 

 

 

Number of
whole
warrants

 

 

Average
exercise
price

 

 

Warrant
value

 

Balance outstanding at March 31, 20211

 

 

127,073,136

 

 

$

58.33

 

 

$

2,568,438

 

Supreme Cannabis warrants

 

 

1,265,742

 

 

 

25.61

 

 

 

13,350

 

Expiry of warrants

 

 

(145,831

)

 

 

32.61

 

 

 

-

 

Balance outstanding at December 31, 20211

 

 

128,193,047

 

 

$

58.04

 

 

$

2,581,788

 

 

1 This balance excludes the Tranche C Warrants, which represent a derivative liability and have nominal value. See Note 29.